1. Home
  2. ALT vs MYD Comparison

ALT vs MYD Comparison

Compare ALT & MYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • MYD
  • Stock Information
  • Founded
  • ALT 1997
  • MYD 1991
  • Country
  • ALT United States
  • MYD United States
  • Employees
  • ALT N/A
  • MYD N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • MYD Investment Bankers/Brokers/Service
  • Sector
  • ALT Health Care
  • MYD Finance
  • Exchange
  • ALT Nasdaq
  • MYD Nasdaq
  • Market Cap
  • ALT 529.9M
  • MYD 479.5M
  • IPO Year
  • ALT N/A
  • MYD N/A
  • Fundamental
  • Price
  • ALT $6.83
  • MYD $10.71
  • Analyst Decision
  • ALT Strong Buy
  • MYD
  • Analyst Count
  • ALT 8
  • MYD 0
  • Target Price
  • ALT $19.71
  • MYD N/A
  • AVG Volume (30 Days)
  • ALT 2.5M
  • MYD 253.1K
  • Earning Date
  • ALT 11-12-2024
  • MYD 01-01-0001
  • Dividend Yield
  • ALT N/A
  • MYD 4.55%
  • EPS Growth
  • ALT N/A
  • MYD N/A
  • EPS
  • ALT N/A
  • MYD N/A
  • Revenue
  • ALT $52,000.00
  • MYD N/A
  • Revenue This Year
  • ALT N/A
  • MYD N/A
  • Revenue Next Year
  • ALT N/A
  • MYD N/A
  • P/E Ratio
  • ALT N/A
  • MYD N/A
  • Revenue Growth
  • ALT N/A
  • MYD N/A
  • 52 Week Low
  • ALT $5.28
  • MYD $8.76
  • 52 Week High
  • ALT $14.84
  • MYD $11.30
  • Technical
  • Relative Strength Index (RSI)
  • ALT 41.57
  • MYD 51.61
  • Support Level
  • ALT $6.19
  • MYD $10.42
  • Resistance Level
  • ALT $7.83
  • MYD $10.66
  • Average True Range (ATR)
  • ALT 0.39
  • MYD 0.10
  • MACD
  • ALT -0.04
  • MYD 0.05
  • Stochastic Oscillator
  • ALT 39.02
  • MYD 97.37

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About MYD Blackrock MuniYield Fund Inc.

Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: